The Division of Hematologic Malignancies is pleased to announce that four faculty members were promoted to the rank of Associate Professor based on their outstanding work. Congratulations to Drs. Debbie...
Congratulations to Dr. Ami Patel for her selection for a Five for the Fight award from HCI. The Five for the Fight program started by Qualtrics seeks to eradicate cancer...
Dr. Afaf Osman was selected as an inaugural recipient of the Dr. Emmy Knobloch Fellowship in Cancer Research. Dr. Osman was selected from HCI members for her research on the...
Congratulations to Dr. Catherine Lee for her appointment as Associate Program Director of the Utah Blood and Marrow Transport and Cellular Therapy Program. She will focus on the operations of...
A research publication coauthored by investigators at ARUP and the Division of Hematology will be published in the journal Blood. The manuscript entitled “The genetic landscape of germline DDX41 variants...
To expand the knowledge surrounding Chronic lymphocytic leukemia (CLL) in minority populations, a study was undertaken by Victoria Vardell, MD, at the University of Utah, and colleagues. Recently, Oncology Times...
Daniel Ermann, second-year hematology/oncology fellow at Huntsman Cancer Institute, has been awarded the Conquer Cancer, ASCO Foundation, Merit Award from the American Society of Clinical Oncology (ASCO) This is a...
One staff member from the Department of Internal Medicine will be highlighted monthly as part of our "From the Desk Of" staff recognition initiative. April's featured staff member is Mandy...
Thank you to everyone who participated in the Huntsman SportsFest, an annual walk/run/ride event raising money to support cancer research, which raised a total of $507,203 this year. 100% of...
Yazan Abou-Ismail, MD, Assistant Professor of Hematology and Hematologic Malignancies at the University of Utah, explains how bleeding and clotting disorders can affect people with cancer.
Two new promising trials at HCI include the I-SPY2 trial, studying new approaches for breast cancer treatment led by Dr. Christos Vaklavas, MD and the SWOG CLL Study S1925, or...
